Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Population Health Investment Co., Inc. | Chief Executive Officer, Director | Class A Ordinary Shares | 11.3K | $111K | $9.79 | Aug 24, 2021 | Direct |
Fractyl Health, Inc. | Director | Common Stock | 278K | Feb 6, 2024 | Indirect | ||
Invivyd, Inc. | Director | Stock Option (Right to Buy) | 50K | May 23, 2023 | Direct | ||
Fractyl Health, Inc. | Director | Stock Option | 45K | Feb 1, 2024 | Direct | ||
Population Health Investment Co., Inc. | Chief Executive Officer, Director | Warrants to purchase Class A Ordinary Share | 20K | Aug 24, 2021 | Direct | ||
EQRx, Inc. | Director | Earn-out Shares | 0 | Nov 9, 2023 | Direct | ||
EQRx, Inc. | Director | Stock Option (Right to Buy) | 0 | Nov 9, 2023 | Direct | ||
Fractyl Health, Inc. | Director | Series F Preferred Stock | 0 | Feb 6, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GUTS | Fractyl Health, Inc. | Feb 6, 2024 | 2 | $0 | 4 | Feb 8, 2024 | Director |
GUTS | Fractyl Health, Inc. | Feb 1, 2024 | 1 | $0 | 4 | Feb 5, 2024 | Director |
GUTS | Fractyl Health, Inc. | Feb 1, 2024 | 0 | $0 | 3 | Feb 1, 2024 | Director |
EQRX | EQRx, Inc. | Nov 9, 2023 | 3 | $0 | 4 | Nov 9, 2023 | Director |
IVVD | Invivyd, Inc. | May 23, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
EQRX | EQRx, Inc. | Jan 1, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
EQRX | EQRx, Inc. | Sep 30, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Director |
IVVD | Adagio Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Mar 28, 2022 | 0 | $0 | 3 | Mar 30, 2022 | Other* |
EQRX | EQRx, Inc. | Dec 17, 2021 | 2 | $0 | 4 | Dec 20, 2021 | Director |
EQRX | EQRx, Inc. | Dec 17, 2021 | 0 | $0 | 3 | Dec 20, 2021 | Director |
PHIC | Population Health Investment Co., Inc. | Aug 24, 2021 | 3 | $176K | 4 | Aug 25, 2021 | Chief Executive Officer, Director |